Last Updated 1 Year(s) ago
For her contributions to veterinary pharmacology, Dr. Dawn M. Boothe is named as the 2012 Hill’s Jack Mara Scientific Achievement Award recipient by the American College of Veterinary Emergency and Critical Care (ACVECC). Dr. Boothe is to receive the award during the International Veterinary Emergency and Critical Care Symposium September 8-12 in San Antonio, Texas, in recognition of her work with “the Unique Pharmacology of the Critically Ill.”
Dr. Boothe is professor and director of the clinical pharmacology and analytical laboratory at the Auburn University College of Veterinary Medicine. She earned her D.V.M. at Texas A&M University, as well as her Ph.D. and M.S. degrees in veterinary physiology. She is board certified by the American College of Veterinary Internal Medicine and the American College of Veterinary Clinical Pharmacology.
Dr. Boothe is recognized for the use of evidence-based data to drive the rational use of drugs in veterinary medicine. She has contributed to small, large, and exotic animal medicine in this context, in addition to mechanistic studies of drug action at the levels of the cell and target organs.
Dr. Boothe has contributed to veterinary understanding of the efficacy and stability of compounded pharmaceuticals. In addition to the widely used textbook “Small Animal Clinical Pharmacology and Therapeutics,” now it its second edition, she has written extensively about the use of antimicrobials in the critically ill patient.
Dr. Boothe will be featured as a key lecturer in the 2013 ACVECC Postgraduate Review Course on “The Unique Pharmacology of the Critically Ill” which is to be held January 19, 2013, in San Juan, Puerto Rico.
The Jack Mara Scientific Achievement Award, sponsored by Hill’s, is presented annually. For this year’s award, ACVECC and Veterinary Emergency and Critical Care Society members nominated veterinarians who made substantial contribution to the knowledge and understanding of the pharmacology of drugs in the critically ill patient or to the unique pharmacologic concerns of veterinary patients with critical illness.